Bright Green Corporation (BGXX)
USD 0.04
(0.0%)
USD 0.04
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -237.01 Thousand USD | 52.7% |
| 2022 | -501.12 Thousand USD | 33.34% |
| 2021 | -751.78 Thousand USD | 10.27% |
| 2020 | -837.85 Thousand USD | -58.64% |
| 2019 | -528.16 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -144.02 Thousand USD | -181.57% |
| 2024 Q1 | -51.15 Thousand USD | 69.3% |
| 2023 Q3 | 4431.00 USD | 110.85% |
| 2023 FY | -237.01 Thousand USD | 52.7% |
| 2023 Q4 | -166.58 Thousand USD | -3859.63% |
| 2023 Q1 | -34 Thousand USD | 68.97% |
| 2023 Q2 | -40.85 Thousand USD | -20.12% |
| 2022 Q2 | -106.29 Thousand USD | 41.19% |
| 2022 Q1 | -180.74 Thousand USD | 0.0% |
| 2022 FY | -501.12 Thousand USD | 33.34% |
| 2022 Q4 | -109.59 Thousand USD | -17.29% |
| 2022 Q3 | -93.43 Thousand USD | 12.09% |
| 2021 Q4 | - USD | 100.0% |
| 2021 FY | -751.78 Thousand USD | 10.27% |
| 2021 Q3 | -189.49 Thousand USD | -1.1% |
| 2021 Q2 | -187.43 Thousand USD | 0.0% |
| 2021 Q1 | - USD | 0.0% |
| 2020 FY | -837.85 Thousand USD | -58.64% |
| 2020 Q4 | - USD | 0.0% |
| 2020 Q3 | - USD | 100.0% |
| 2020 Q2 | -208.32 Thousand USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2019 FY | -528.16 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 326.16 Million USD | 100.073% |
| China SXT Pharmaceuticals, Inc. | 553.97 Thousand USD | 142.785% |
| Embecta Corp. | 749.9 Million USD | 100.032% |
| Pacira BioSciences, Inc. | 490.3 Million USD | 100.048% |
| PainReform Ltd. | -15 Thousand USD | -1480.107% |
| Sunshine Biopharma, Inc. | 8.33 Million USD | 102.842% |
| SCYNEXIS, Inc. | 124.51 Million USD | 100.19% |
| Journey Medical Corporation | 52.52 Million USD | 100.451% |
| Safety Shot Inc | -74.45 Thousand USD | -218.326% |
| Alpha Teknova, Inc. | 10.29 Million USD | 102.302% |
| Procaps Group, S.A. | 239.56 Million USD | 100.099% |
| Alvotech | -69.42 Million USD | 99.659% |
| ANI Pharmaceuticals, Inc. | 305.3 Million USD | 100.078% |
| Aquestive Therapeutics, Inc. | 29.75 Million USD | 100.797% |
| Cosmos Health Inc. | 4.34 Million USD | 105.449% |
| Dynavax Technologies Corporation | 182.11 Million USD | 100.13% |
| Esperion Therapeutics, Inc. | 73.06 Million USD | 100.324% |
| Intra-Cellular Therapies, Inc. | 430.62 Million USD | 100.055% |
| Sunshine Biopharma, Inc. | 8.33 Million USD | 102.842% |
| Theratechnologies Inc. | 62.12 Million USD | 100.381% |
| Harrow Health, Inc. | 90.55 Million USD | 100.262% |
| Sonoma Pharmaceuticals, Inc. | 4.74 Million USD | 104.995% |
| Biofrontera Inc. | 16.62 Million USD | 101.425% |
| DURECT Corporation | 6.83 Million USD | 103.47% |
| Supernus Pharmaceuticals, Inc. | 523.74 Million USD | 100.045% |
| Cronos Group Inc. | 6.99 Million USD | 103.39% |
| OptiNose, Inc. | 62.35 Million USD | 100.38% |
| Ironwood Pharmaceuticals, Inc. | 441.16 Million USD | 100.054% |
| Kala Pharmaceuticals, Inc. | -303 Thousand USD | 21.777% |
| RedHill Biopharma Ltd. | 3.05 Million USD | 107.76% |
| Organogenesis Holdings Inc. | 309.79 Million USD | 100.077% |
| Guardion Health Sciences, Inc. | 5.39 Million USD | 104.394% |
| Cumberland Pharmaceuticals Inc. | 33.48 Million USD | 100.708% |
| Radius Health, Inc. | 307.71 Million USD | 100.077% |
| Universe Pharmaceuticals INC | 10.07 Million USD | 102.352% |
| ProPhase Labs, Inc. | 16.23 Million USD | 101.46% |
| Phibro Animal Health Corporation | 312.48 Million USD | 100.076% |
| Procaps Group S.A. | 239.56 Million USD | 100.099% |
| TherapeuticsMD, Inc. | 1.3 Million USD | 118.204% |
| Viatris Inc. | 6.43 Billion USD | 100.004% |
| Rockwell Medical, Inc. | 8.7 Million USD | 102.723% |
| Aytu BioPharma, Inc. | 54.58 Million USD | 100.434% |
| SIGA Technologies, Inc. | 122.09 Million USD | 100.194% |
| Tilray Brands, Inc. | 223.35 Million USD | 100.106% |
| Lifecore Biomedical, Inc. | 41.85 Million USD | 100.566% |
| Shineco, Inc. | 882.16 Thousand USD | 126.867% |
| PetIQ, Inc. | 252.74 Million USD | 100.094% |
| Regencell Bioscience Holdings Limited | -745.58 Thousand USD | 68.211% |
| Incannex Healthcare Limited | 12 Thousand USD | 2075.133% |
| Neurocrine Biosciences, Inc. | 1.84 Billion USD | 100.013% |
| Alimera Sciences, Inc. | 61.17 Million USD | 100.387% |
| Silver Spike Investment Corp. | 8.1 Million USD | 102.925% |
| Assertio Holdings, Inc. | 125.04 Million USD | 100.19% |
| Shuttle Pharmaceuticals Holdings, Inc. | -6811.00 USD | -3379.9% |
| Petros Pharmaceuticals, Inc. | 4.19 Million USD | 105.655% |
| Clever Leaves Holdings Inc. | 6.55 Million USD | 103.615% |
| Cyclo Therapeutics, Inc. | -2.41 Million USD | 90.166% |
| Avadel Pharmaceuticals plc | 27.11 Million USD | 100.874% |
| Hempacco Co., Inc. | -1.21 Million USD | 80.506% |
| Talphera, Inc. | -4.89 Million USD | 95.158% |
| Alvotech | -69.42 Million USD | 99.659% |
| Eagle Pharmaceuticals, Inc. | 221.67 Million USD | 100.107% |
| Lantheus Holdings, Inc. | 709.54 Million USD | 100.033% |
| Currenc Group, Inc. | 17.35 Million USD | 101.366% |
| Kamada Ltd. | 52.59 Million USD | 100.451% |
| Indivior PLC | 907 Million USD | 100.026% |
| Evoke Pharma, Inc. | 4.97 Million USD | 104.761% |
| Flora Growth Corp. | 17.73 Million USD | 101.336% |
| Cyclo Therapeutics, Inc. | -2.41 Million USD | 90.166% |
| Evolus, Inc. | 140.52 Million USD | 100.169% |
| HUTCHMED (China) Limited | 453.55 Million USD | 100.052% |
| Amphastar Pharmaceuticals, Inc. | 343.96 Million USD | 100.069% |
| Akanda Corp. | 111.44 Thousand USD | 312.668% |